
Please try another search
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology, rheumatology, and the central nervous system. It also provides API products for antidiabetics, antihistamines, antitussives, analgesics, antidepressants, and anti-inflammatory medicines. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Name | Age | Since | Title |
---|---|---|---|
Pravin Dilip Pawar | - | 2023 | Non-Executive Independent Director |
Anupama Vaidya | 53 | 2023 | Non-Executive Independent Woman Director |
Mridul Sumanlal Mehta | 59 | 2024 | Non-Executive Independent Director |
Manojkumar Khubchand Gursahani | - | 2025 | Additional Non-Executive Independent Director |
Pallavur Sankar Dass Vaidyanathan | - | 2025 | Additional Non-Executive Independent Director |
Mohan Kumar Rayana | 66 | 2023 | Whole Time Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review